Table 2 Reported treatment of MOGCT and SCST: incident cases of 2016–2021.
MOGCT Total = 629 | SCST Total = 872 | |||
|---|---|---|---|---|
n | % | n | % | |
Surgery | 363/629 | 58 | 633/872 | 73 |
Laparoscopy | 96/363 | 26 | 241/633 | 38 |
Laparotomy | 153/363 | 42 | 223/633 | 35 |
missing data on type of operation | 114/363 | 31 | 169/633 | 27 |
Adnexectomy* | 293/363 | 81 | 507/633 | 80 |
Omentectomy* | 147/363 | 40 | 334/633 | 53 |
Peritonectomy* | 140/363 | 39 | 294/633 | 46 |
Hysterectomy* | 84/363 | 23 | 325/633 | 51 |
ovarian cystectomy* | 34/363 | 9 | 24/633 | 4 |
Paraaortal lymphadenectomy* | 30/363 | 8 | 35/633 | 6 |
Other* | 77/363 | 21 | 97/633 | 15 |
Chemotherapy | 165/629 | 26 | 68/872 | 8 |
Carboplatin* | 43/165 | 26 | 56/68 | 82 |
Cisplatin* | 121/165 | 73 | 13/68 | 19 |
Paclitaxel* | 34/165 | 21 | 47/68 | 69 |
Etoposide* | 126/165 | 76 | 12/68 | 18 |
Bleomycin* | 61/165 | 40 | 9/68 | 13 |
Ifosfamide* | 32/165 | 19 | 0 | |
Other* | 34/165 | 21 | 11/68 | 16 |
Radiotherapy | 14/629 | 2 | < 6/872 | < 1 |